Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

City Attorney Launches Probe After CNN Details Rising Use of Nuedexta Among Los Angeles Nursing Home Patients

The City Attorney for Los Angeles has launched a new investigation, following broadcast of a CNN report detailing the rising use of Nuedexta among elderly nursing home patients, especially in Southern California. According to the cable network, Mark Feuer is … Continue reading

Court Overseeing Levaquin, Cipro and Avelox Lawsuits Amends Bellwether Trial Schedule

Peripheral neuropathy lawsuits involving Avelox, Cipro and Levaquin continue to move forward in the multidistrict litigation currently underway in the U.S. District Court, District of Minnesota. According to an Order dated October 12th, the Court has amended the pretrial schedule … Continue reading

Parties to Atrium C-Qur Hernia Mesh Lawsuit Parties Preparing for “Science Day”

Hernia mesh lawsuits involving Atrium Medical Corp.’s C-Qur devices continue to move forward in the U.S. District Court, District of New Hampshire, where all such federally-filed claims have been consolidated for the purpose of coordinated pretrial proceedings. According to a … Continue reading

Studies Suggest Proton Pump Inhibitors May Have Contributed to Rising Incidence of Chronic Liver Disease

A series of studies conducted by University of California San Diego researchers suggest that proton pump inhibitors like Nexium may be contributing to the rising incidence of chronic kidney disease. The research, which appears in Nature Communications, involved mouse models, … Continue reading

341 DePuy Pinnacle Hip Replacement Lawsuit Plaintiffs Head to Trial in the U.K.

The U.K.’s first trial involving a metal-on-metal version of DePuy Orthopaedics Pinnacle Hip Replacement System got underway this week in London. The case involves 341 plaintiffs and according to Bloomberg News, is one of the largest product liability group actions … Continue reading

Recent Hernia Mesh Lawsuit Filings Include Claims Against Ethicon, C.R. Bard

Two new hernia mesh lawsuits have been filed on behalf of plaintiffs who allegedly suffered serious complications following implantation of Ethicon, Inc.’s Physiomesh product and C.R. Bard, Inc.’s Ventralex ST device. Bard Ventralex ST Hernia Mesh Blamed for Hernia Recurrence … Continue reading

Risk of Xarelto Bleeding Side Effects May Increase When Combined with Certain Medications

A new study suggests that the potential for bleeding side effects associated with Xarelto and other new-generation blood thinners may increase if the drugs are used in combination with certain medications, including amiodarone, Rifadin, Diflucan, and Dilantin. According to a … Continue reading

JPML Refuses to Vacate Order Transferring Taxotere Lawsuit to Federal Hair Loss Litigation in Louisiana

The U.S. Judicial Panel on Multidistrict Litigation (JPML) continues to transfer Taxotere lawsuits to the U.S. District Court, Eastern District of Louisiana, where all federally-filed product liability claims involving the medication’s alleged association with permanent hair loss have been centralized … Continue reading

Wright Medical Adds $90 Million to $240 Million Hip Replacement Settlement

Wright Medical Technology has added $90 million to a $240 million hip replacement settlement the company announced last year to resolve product liability claims involving several of its metal-on-metal hip implant products. The original Wright hip replacement settlement was announced … Continue reading

Risperdal Lawsuit Plaintiff Given Leave to Amend Off-Label Marketing Claims Against Generic Drug Maker

A Risperdal lawsuit plaintiff will be permitted to amend his off-label marketing claims against two generic drug makers, after a Texas federal judge found that the allegations were inadequately pled. According to, Malcom Wydermyer alleges that his use of … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest